Over the past two decades, the idea of targeting transcription factors to combat malignancies has turned into a clinical reality.

Dewpoint Therapeutics’ second development candidate, DPTX3496 is an oral, small molecule acting via a novel ...

Research on the development, physiology and pathophysiology of reproductive disorders is important, as evidence suggests that many adult-onset diseases can be traced back to disruptions during early ...

Lutris Pharma, a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing cutaneous ...

Glaucoma is a complex and multifactorial neurodegenerative disorder primarily characterized by the progressive loss of retinal ganglion cells (RGCs) and their axons, leading to irreversible visual ...

Turmeric (Curcuma longa), a vibrant yellow spice, a rhizomatous herbaceous plant from the ginger family (Zingiberaceae), has ...

Dihydromyricetin (Dih), a naturally occurring flavonoid, has been identified to exert a protective effect against ischemia/reperfusion injury. However, the detailed mechanisms remain unclear. Here we ...

Most people associate sunburns with DNA damage -- it's what we've been taught in textbooks and by dermatologists for years.

Cartalax peptide, a bioregulator derived from cartilage tissue, has garnered significant interest in scientific communities ...

Researchers examine how long-term exposure to widely used per- and polyfluoroalkyl substances (PFAS) detrimentally affect ...

The surprising paradigm shift could lead to much more protective sunscreens and effective skin treatments.

A combination therapy of two drugs — a statin and a protein inhibitor — may help suppress the creation and growth of tumors ...